| Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. (NCT05354115) | Abbott Rapid Dx | 2022-03-14 |
| CC-42344 Safety Study in Healthy Participants (NCT05202379) | Cocrystal Pharma, Inc. | 2022-02-11 |
| Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment (NCT05268939) | LumiraDx UK Limited | 2022-01-04 |
| Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel (NCT05163730) | Abbott Rapid Diagnostics Jena GmbH | 2021-11-01 |
| Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® (NCT04896853) | NextCell Pharma Ab | 2021-05-18 |
| Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19 (NCT04653727) | Charite University, Berlin, Germany | 2021-01-06 |
| A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A (NCT04683406) | Guangdong Raynovent Biotech Co., Ltd | 2020-12-28 |
| Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml (NCT04810949) | Hospital Clinica Nova | 2020-08-05 |
| Home Testing of Respiratory Illness (NCT04245800) | Evidation Health | 2019-12-13 |
| Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A (NCT04024137) | Guangdong Raynovent Biotech Co., Ltd | 2019-12-07 |
| Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines (NCT03999554) | FluGen Inc | 2019-09-03 |
| Study to Assess Safety, Tolerability and Reactogenicity of Vaccine "UniFluVec" After Two Intranasal Administrations in Healthy Volunteers (NCT04650971) | Pharmenterprises Biotech LLC | 2019-08-29 |
| Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults (NCT03743688) | Vanderbilt University Medical Center | 2018-12-04 |
| The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac (NCT03651544) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-10-15 |
| A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications (NCT03381196) | Janssen Research & Development, LLC | 2018-01-21 |
| Flufenamic Acid for Hospitalised Influenza Infection (NCT03238612) | The University of Hong Kong | 2018-01-08 |
| Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A (NCT03040141) | Visterra, Inc. | 2018-01-03 |
| A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection (NCT03376321) | Janssen Research & Development, LLC | 2018-01-03 |
| Biomarkers Predicting Infectivity in an Experimental Human Influenza Model (NCT03207152) | Duke University | 2017-09-11 |
| A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection (NCT03511066) | Celltrion | 2016-12-09 |
| A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults (NCT02623322) | Genentech, Inc. | 2016-10-12 |
| Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B (NCT02767414) | Ellume Pty Ltd | 2016-07-01 |
| Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population (NCT03196661) | Hualan Biological Bacterin Co. Ltd. | 2015-11-06 |
| Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B (NCT02487173) | Ellume Pty Ltd | 2015-09-01 |
| Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza (NCT02287467) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-01-01 |
| Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects (NCT02342249) | Janssen Research & Development, LLC | 2014-12-11 |
| A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model (NCT02071914) | Celltrion | 2014-02-15 |
| Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer (NCT02067286) | IQuum, Inc. | 2014-01-01 |
| Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers (NCT02014870) | Immune Targeting Systems Ltd | 2013-06-01 |
| Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults (NCT01701752) | Immune Targeting Systems Ltd | 2012-09-01 |
| Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1) (NCT01677676) | Immune Targeting Systems Ltd | 2012-01-01 |
| Collection and Testing of Respiratory Samples (NCT01302418) | QIAGEN Gaithersburg, Inc | 2011-02-01 |
| Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza (NCT01052480) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-12-01 |
| Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7 (NCT00922259) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Convalescent Plasma Treatment in Severe 2009 H1N1 Infection (NCT01306773) | The University of Hong Kong | 2009-12-01 |
| The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients (NCT00987012) | Hillel Yaffe Medical Center | 2009-10-01 |